Expert Guidance on New Advances in Renal Cell Carcinoma

To claim CME/NCPD credit for this podcast, visit i3health.com/oda-renal-cell-carcinoma Kidney cancer accounts for approximately 4% of all cancer diagnoses in the United States. An estimated 73,750 new cases are reported annually and 14,830 people die of the disease. Renal cell carcinoma, which comprises nearly 90% of all kidney cancers, is characterized by a lack of early warning signs, diverse clinical manifestations, and resistance to radiation and chemotherapy. Bradley McGregor, MD, and Robert Motzer, MD, discuss first-line and second-line treatment options for advanced renall cell carcinoma on this episode of Oncology Data Advisor.